![]()
|
|
||||||||
(Received for publication, June 18, 1997, and in revised form, August 13, 1997)
From the Department of Biochemistry and Center in Molecular
Toxicology, Vanderbilt University School of Medicine,
Nashville, Tennessee 37232-0146
A number of cytochrome P450 (P450) 2E1 substrates
are known to show kinetic deuterium isotope effects of ~5 on
Km (DK = DKm/HKm),
but not on kcat, in rat liver microsomes
(e.g. N-nitrosodimethylamine, ethanol, and
CH2Cl2). We observed
DKm values of 3-5 for recombinant
human P450 2E1-catalyzed ethanol oxidation. Replacing NADPH and
O2 with the oxygen surrogate cumene hydroperoxide yielded
similar results. Ferric P450 2E1 reduction was fast (k
>1000 min
Volume 272, Number 47,
Issue of November 21, 1997
pp. 29643-29651
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Oxidation Kinetics of Ethanol by Human Cytochrome P450 2E1
RATE-LIMITING PRODUCT RELEASE ACCOUNTS FOR EFFECTS OF ISOTOPIC
HYDROGEN SUBSTITUTION AND CYTOCHROME b5 ON
STEADY-STATE KINETICS
1) even in the absence of substrate. These
results indicate that the basis for the increase in
Km is in the latter portion of the catalytic cycle.
The intrinsic isotope effect (Dk) for ethanol
oxidation was determined (competitively) to be 3.8, indicating that
C-H bond cleavage is isotopically sensitive. Pre-steady-state studies
showed a burst of product formation (k = 410 min
1), with the burst amplitude corresponding to the P450
concentration. Deuteration of ethanol resulted in an isotope effect of
3.2 on the rate of the burst. We conclude that product release is
rate-limiting in the oxidation of ethanol to acetaldehyde by P450 2E1.
The steady-state kinetics can be described by a paradigm in which the
kcat approximates the rate of product release,
and Km is an expression in which the denominator is
dominated by the rate of C-H bond breaking.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. A. Krauser and F. P. Guengerich Cytochrome P450 3A4-catalyzed Testosterone 6{beta}-Hydroxylation Stereochemistry, Kinetic Deuterium Isotope Effects, and Rate-limiting Steps J. Biol. Chem., May 20, 2005; 280(20): 19496 - 19506. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. M. Miller, J. Cai, S. L. Ripp, W. M. Pierce Jr., T. H. Rushmore, and R. A. Prough STEREO- AND REGIOSELECTIVITY ACCOUNT FOR THE DIVERSITY OF DEHYDROEPIANDROSTERONE (DHEA) METABOLITES PRODUCED BY LIVER MICROSOMAL CYTOCHROMES P450 Drug Metab. Dispos., March 1, 2004; 32(3): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Guengerich, G. P. Miller, I. H. Hanna, H. Sato, and M. V. Martin Oxidation of Methoxyphenethylamines by Cytochrome P450 2D6. ANALYSIS OF RATE-LIMITING STEPS J. Biol. Chem., September 6, 2002; 277(37): 33711 - 33719. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Chung, S. H. Kim, M. G. Lee, and S. G. Kim Increase in Urea in Conjunction with L-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure Drug Metab. Dispos., June 1, 2002; 30(6): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Upthagrove and W. L. Nelson Importance of Amine pKa and Distribution Coefficient in the Metabolism of Fluorinated Propranolol Derivatives. Preparation, Identification of Metabolite Regioisomers, and Metabolism by CYP2D6 Drug Metab. Dispos., November 1, 2001; 29(11): 1377 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Robertson, I. Leclercq, and G. C. Farrell Nonalcoholic Steatosis and Steatohepatitis: II. Cytochrome P-450 enzymes and oxidative stress Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1135 - G1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Guengerich Metabolism of chemical carcinogens Carcinogenesis, March 1, 2000; 21(3): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Bell-Parikh and F. P. Guengerich Kinetics of Cytochrome P450 2E1-Catalyzed Oxidation of Ethanol to Acetic Acid via Acetaldehyde J. Biol. Chem., August 20, 1999; 274(34): 23833 - 23840. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Guengerich, N. A. Hosea, A. Parikh, L. C. Bell-Parikh, W. W. Johnson, E. M. J. Gillam, and T. Shimada Twenty Years of Biochemistry of Human P450s. Purification, Expression, Mechanism, and Relevance to Drugs Drug Metab. Dispos., December 1, 1998; 26(12): 1175 - 1178. [Abstract] [Full Text] |
||||
![]() |
Proceedings of the British Toxicology Society Annual Congress University of Surrey, Guildford 19 - 22 April 1998 Human and Experimental Toxicology, September 1, 1998; 17(9): 469 - 534. [PDF] |
||||
![]() |
S. Kominami, A. Owaki, T. Iwanaga, H. Tagashira-Ikushiro, and T. Yamazaki The Rate-determining Step in P450 C21-catalyzing Reactions in a Membrane-reconstituted System J. Biol. Chem., March 30, 2001; 276(14): 10753 - 10758. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |